Remove Disease Remove Drug Development Remove Molecular Biology Remove Workshop
article thumbnail

Turning science into business: Merging AI and RNA

Drug Discovery World

For founders planning to launch their start-ups, specifically drug developers, there needs to be sound, foundational science with promising data that will enable you to push further down the drug discovery pipeline. Do you have any therapeutic targets in mind for your first small molecule drug candidate?

RNA 130
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

The brainchild of multidisciplinary experts in computer science, physics, engineering, and biology, the field of synthetic biology has not only rapidly progressed in the last few decades but it’s also becoming more accessible and cost-effective. Synthetic libraries for antibody drug discovery .

DNA 246
article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Instead, molecular markers are more accurate indicators of the patient’s associated risks. .

Research 130